GenMont Biotech (TPE:3164) Cyclically Adjusted Book per Share: NT$18.48 (As of Dec. 2025)


TPE:3164 GenMont Biotech Inc TPE:3164
82 GF Score
Price NT$16.55
GF Value NT$26.24
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is GenMont Biotech Cyclically Adjusted Book per Share?

GenMont Biotech TPE:3164 +0.30% 82 Cyclically Adjusted Book per Share is NT$18.48 as of Dec. 2025. GuruFocus rates TPE:3164 with a GF Score™ of 82/100 and a GF Value™ of NT$26.24 (Significantly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

GenMont Biotech's adjusted book value per share for the three months ended in Dec. 2025 was NT$15.474. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$18.48 for the trailing ten years ended in Dec. 2025.

During the past 12 months, GenMont Biotech's average Cyclically Adjusted Book Growth Rate was -1.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 0.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 2.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of GenMont Biotech was 4.70% per year. The lowest was 0.20% per year. And the median was 3.55% per year.

As of today (2026-07-08), GenMont Biotech's current stock price is NT$16.55. GenMont Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was NT$18.48. GenMont Biotech's Cyclically Adjusted PB Ratio of today is 0.90.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of GenMont Biotech was 1.63. The lowest was 0.86. And the median was 1.31.


GenMont Biotech  (TPE:3164) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

GenMont Biotech's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=16.55/18.48
=0.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of GenMont Biotech was 1.63. The lowest was 0.86. And the median was 1.31.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


GenMont Biotech Cyclically Adjusted Book per Share Related Terms


GenMont Biotech Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for GenMont Biotech's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GenMont Biotech Cyclically Adjusted Book per Share Chart

GenMont Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.42 18.36 18.65 18.83 18.48

GenMont Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.83 18.86 18.80 18.71 18.48

TPE:3164 vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, GenMont Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GenMont Biotech Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GenMont Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where GenMont Biotech's Cyclically Adjusted PB Ratio falls into.


TPE:3164
82GF Score
GenMont Biotech Inc TPE:3164
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GenMont Biotech Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, GenMont Biotech's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=15.474/324.0540*324.0540
=15.474

Current CPI (Dec. 2025) = 324.0540.

GenMont Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201603 16.806 238.132 22.870
201606 16.823 241.018 22.619
201609 16.745 241.428 22.476
201612 14.392 241.432 19.317
201703 14.361 243.801 19.088
201706 14.889 244.955 19.697
201709 15.069 246.819 19.784
201712 15.039 246.524 19.769
201803 15.128 249.554 19.644
201806 16.155 251.989 20.775
201809 16.452 252.439 21.119
201812 16.766 251.233 21.626
201903 17.344 254.202 22.110
201906 15.802 256.143 19.992
201909 15.701 256.759 19.816
201912 15.573 256.974 19.638
202003 15.580 258.115 19.560
202006 14.714 257.797 18.496
202009 15.147 260.280 18.858
202012 15.396 260.474 19.154
202103 15.675 264.877 19.177
202106 15.772 271.696 18.811
202109 15.333 274.310 18.114
202112 15.936 278.802 18.523
202203 16.563 287.504 18.669
202206 15.451 296.311 16.898
202209 15.621 296.808 17.055
202212 15.646 296.797 17.083
202303 15.094 301.836 16.205
202306 14.876 305.109 15.800
202309 15.407 307.789 16.221
202312 15.215 306.746 16.073
202403 15.246 312.332 15.818
202406 15.475 314.175 15.962
202409 15.662 315.301 16.097
202412 15.626 315.605 16.044
202503 15.156 319.799 15.358
202506 14.340 322.561 14.406
202509 14.861 324.800 14.827
202512 15.474 324.054 15.474

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$18.48 mean?
GenMont Biotech (TPE:3164) has a Cyclically Adjusted Book per Share of NT$18.48 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on GenMont Biotech and its competitors.
Is GenMont Biotech's Cyclically Adjusted Book per Share too high?
GenMont Biotech's current Cyclically Adjusted Book per Share is NT$18.48. Overall, GenMont Biotech has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GenMont Biotech's Cyclically Adjusted Book per Share compare to VRTX and REGN?
GenMont Biotech's Cyclically Adjusted Book per Share of NT$18.48 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on GenMont Biotech and its competitors. GenMont Biotech's current Cyclically Adjusted Book per Share is NT$18.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GenMont Biotech stock overvalued right now?
Based on GuruFocus' analysis, GenMont Biotech (TPE:3164) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$26.24, compared to a current price of NT$16.55 — trading 36.9% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$18.48. GenMont Biotech's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For GenMont Biotech (TPE:3164), the current Cyclically Adjusted Book per Share is NT$18.48 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GenMont Biotech (TPE:3164) Overvalued in 2026?

Based on GuruFocus' analysis, GenMont Biotech stock appears to be undervalued. The current stock price of NT$16.55 is trading 36.9% below its estimated GF Value™ of NT$26.24. GuruFocus considers GenMont Biotech to be Significantly Undervalued.

Key valuation signals for TPE:3164:

  • Cyclically Adjusted Book per Share: NT$18.48
  • GF Value™: NT$26.24 vs. price of NT$16.55 (36.9% below fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the TPE:3164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


GenMont Biotech Business Description

Address No. 8 Nanke 7th Road, Tainan Science and Technology Park, Shanhua District, Tainan, TWN, 741014
GenMont Biotech Inc is engaged in the research, development, manufacturing, and selling of a variety of probiotic supplements. The Group mainly engages in the manufacturing and selling of functional foods, its single operating segment.
82GF Score

Get the complete analysis for TPE:3164

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.55
Price
NT$26.24
GF Value